Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Scope Of Practice topic
No spam. Unsubscribe anytime.
Mississippi Board of Nursing: ketamine for depression not within nursing scope
Summary
The Mississippi Board of Nursing on Feb. 7 voted unanimously to reiterate that the administration of ketamine for treatment of depression is outside the nursing scope of practice and directed publication of advisory opinions suggested by the Practice Committee.
Board President Sandra Culpepper presided over a Feb. 7, 2025, meeting in Ridgeland where the Mississippi Board of Nursing voted to reaffirm that administering ketamine for the treatment of depression is not within the nursing scope of practice. The motion was made by Janel Moody and seconded by Jeremy Cummins; the board voted unanimously.
The board’s action formalizes the Practice Committee’s recommendation and follows an Executive Committee recommendation to publish advisory opinions suggested by the Practice Committee so that the board’s positions are publicly available. The board voted unanimously to adopt the Executive Committee’s recommendation, on a motion by Sandra Culpepper and seconded by Jeremy Cummins.
The decisions were procedural policy determinations: the board reiterated its interpretation of the nursing scope of practice and approved publication of advisory opinions to clarify that interpretation. The board record does not include additional clinical guidance or a timeline for publication.
The votes were unanimous; no members of the public attended the meeting in person. The board meeting took place at the board office in Ridgeland.
